Evidence-based clinical guidelines for immigrants and refugees

TY - JOUR

T1 - Evidence-based clinical guidelines for immigrants and refugees

AU - MacDonald, Noni E.

AU - Kutcher, Stan

N1 - Funding Information: Funding: The Public Health Agency of Canada (PHAC) contributed funding for the development and publication of reviews of the scientific evidence on select topics related to PHAC programs of work. The conclusions and recommendations made in the guidelines were independently developed by the Canadian Collaboration for Immigrant and Refugee Health. The views expressed in this report are the views of the authors and do not necessarily reflect those of PHAC or any other agency that provided funding support. In addition to the support from PHAC, the Canadian Collaboration for Immigrant and Refugee Health acknowledges funding support for this project from the Canadian Institutes of Health Research (Institute of Health Services and Policy Research), the Champlain Local Health Integrated Network and the Calgary Refugee Program. The Calgary Refugee Program, the Champlain Local Health Integrated Network and the Canadian Institutes of Health Research (Canadian Institute of Health Services and Policy Research) contributed to dissemination of the guidelines. The Office of the Chief Dental Officer, Health Canada, provided support for the evidence review on dental health (section 18). Anita J. Gagnon's participation in the project was supported by McGill University through a William Dawson Scholarship. Christina Greenaway receives salary support from the Fonds de la recherche en santé du Québec (FRSQ) through the Chercheur Boursier Clinicien. Carmen Logie receives funding support from the Social Sciences and Humanities Research Council of Canada through a doctoral fellowship. Dick Menzies receives salary support from the FRSQ through the Chercheur National program. Brett Thombs is supported by a New Investigator Award from the Canadian Institutes of Health Research and an Établissement de Jeunes Chercheurs award from the FRSQ. Funding Information: Competing interests: Elizabeth Barnett has received grant funding (through her institution) from Sanofi Pasteur and Intercell for work unrelated to this publication; funding for lectures from Merck; royalties from Elsevier; and funding for development of educational presentations from PriMed. She has also received payment for expert testimony. Jennifer Blake is the associate chair of the Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, which has received unrestricted educational grants from pharmaceutical companies in support of educational services; she is vice-chair of Genesis Research Foundation, which receives philanthropic donations from many organizations and which funds research trainees; she is chair of the Canadian Foundation for Women's Health, which receives philanthropic gifts and funds research; and she has served on advisory boards in contraception and has received honoraria for lectures. Marc Deschenes has attended meetings of the Gilead Sciences Advisory Board. Sheila Dunn was on the advisory board of Trimedic in 2008, received speaker fees from Paladin Labs in 2008, received research grants for clinical trials of contraceptives from Organon (Schering-Plough) and provided information (without compensation) to the National Drug Safety and Advisory Committee, in collaboration with Paladin Labs, to support deregulation of emergency contraception in 2007. John Feightner has advised and consulted with the Canadian Task Force on Preventive Health Care. Elizabeth Harvey has served as a national advisory board member for Sanofi Aventis and as a consultant for Lifescan; and her institution receives program funding from the Ontario Diabetes Strategy. In addition, Pfizer, Becton Dickinson, Novo-Nordisk, Eli Lilly, Sanofi Aventis, Bayer, Merck, Astra Zeneca and Bristol Myers Squibb have provided grants to her institution and payments for lectures related to the development and presentation of educational programs about diabetes for primary care providers. Jenny Heathcote has served as a consultant to Axcan Pharma, Gilead Sciences, Hoffmann-La Roche, Merck, Schering-Plough and Tibotec; has received restricted grants from Axcan Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Debio Pharma, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Human Genome Sciences, Intercept Pharmaceuticals, Schering-Plough, Tibotec and Vertex; has received unrestricted grants from Axcan Pharma, Boehringer Ingelheim, Gilead Sciences, Hoffmann-La Roche, Schering-Plough and Vertex; and has received speaker's fees from Axcan Pharma, Gilead Sciences, Hoffmann-La Roche, Schering-Plough and Tibotec. Charles Hui has received grant support through his institution, as well as payment for lectures and travel expenses, from Abbott International, and has also served on a scientific advisory board for Novartis. Jay Keystone has received speaker fees and payments for development of educational presentations from GlaxoSmithKline, Sanofi Pasteur and Merck. Stan Kutcher occasionally serves as an expert witness. Noni MacDonald, Section Editor, Population and Public Health, CMAJ, is a coauthor of this article; she was not involved in the vetting of this article before publication. Anne McCarthy has served as an ad hoc consultant on travel medicine to Shore-lands Inc. Lavanya Narasiah received speaker fees from GlaxoSmithKline for presentations on travel health. Pierre Plourde received speaker fees from GlaxoSmithKline for presentations on travel health and tropical medicine. Peter Tugwell, chair of the CMA Journal Oversight Committee, is a coauthor of this article; he was not involved in the vetting of this article before publication. David Wong has received educational grants related to hosting the University of Toronto Sheila Sherlock Liver Research Day and the University of Toronto Hepatology Update; he also has received honoraria for educational sessions from Roche, Schering, Gilead, Bristol-Myers Squibb and Novartis (in all instances, the slides used for sessions have been his own). No competing interests declared by Deborah Assayag, Beverly Brockest, Ralf Buhrmann, Giovani Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Marianne Cheetham, Walter Delpero, Shafik Dharamsi, Arunmozhi Dominic, Ann Duggan, Nancy Durand, Allison Eyre, Anita Gagnon, Jennifer Grant, Christina Greenaway, Doug Gruner, Sinclair Harris, Stewart Harris, Ghayda Hassan, Christine Heidebrecht, Willam Hodge, Danielle Hone, Susan Hum, Praseedha Janakiram, Khairun Jivani, Tomas Jurcik, Kamran Khan, Laurence Kirmayer, Ian Kitai, Srinivasan Krishnamurthy, Susan Kuhn, Robert LaRoche, Carmen Logie, Michelle Martin, Dominique Elien Massenat, Debora Matthews, Barry Maze, Mary McNally, Dick Menzies, Marie Munoz, Félicité Murangira, Amy Nolen, Kevin Pottie, Meb Rashid, Cécile Rousseau, Hélène Rousseau, Andrew Ryder, Amelia Sandoe, Kevin Schwartzman, Jennifer Sears, William Stauf-fer, Helena Swinkels, Brett Thombs, Patricia Topp, Andrew Toren, Sara Torres, Erin Ueffing, Ahsan Ullah, Sunil Varghese, Bilkis Vissandjee, Vivian Welch, Mchel Welt, Wendy Wobeser, Phyllis Zelkowitz, Jianwei Zhong, Stanley Zlotkin.

PY - 2011/9/6

Y1 - 2011/9/6

UR - http://www.scopus.com/inward/record.url?scp=80052596520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052596520&partnerID=8YFLogxK

U2 - 10.1503/cmaj.090313

DO - 10.1503/cmaj.090313

M3 - Article

AN - SCOPUS:80052596520

SN - 0820-3946

VL - 183

SP - E824-E925

JO - CMAJ

JF - CMAJ

IS - 12

ER -